The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Authors
Keywords
-
Journal
NATURE REVIEWS MICROBIOLOGY
Volume 12, Issue 3, Pages 159-167
Publisher
Springer Nature
Online
2014-02-03
DOI
10.1038/nrmicro3200
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced Drug Uptake in Phenotypically Resistant Nutrient-Starved Nonreplicating Mycobacterium tuberculosis
- (2013) Jansy Sarathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A medicinal chemists’ guide to the unique difficulties of lead optimization for tuberculosis
- (2013) Véronique Dartois et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Polyamines Inhibit Porin-Mediated Fluoroquinolone Uptake in Mycobacteria
- (2013) Jansy Passiflora Sarathy et al. PLoS One
- Dynamic Persistence of Antibiotic-Stressed Mycobacteria
- (2013) Y. Wakamoto et al. SCIENCE
- Spontaneous Latency in a Rabbit Model of Pulmonary Tuberculosis
- (2012) Selvakumar Subbian et al. AMERICAN JOURNAL OF PATHOLOGY
- 3D Imaging by Mass Spectrometry: A New Frontier
- (2012) Erin H. Seeley et al. ANALYTICAL CHEMISTRY
- Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles
- (2012) Daniel L. Clemens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [18F]2-Fluoro-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography
- (2012) Laura E. Via et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Noninvasive Determination of 2-[18F]-Fluoroisonicotinic Acid Hydrazide Pharmacokinetics by Positron Emission Tomography in Mycobacterium tuberculosis-Infected Mice
- (2012) E. A. Weinstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis
- (2012) Emily R. Driver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Tuberculous Granuloma: An Unsuccessful Host Defence Mechanism Providing a Safety Shelter for the Bacteria?
- (2012) Mayra Silva Miranda et al. Clinical & Developmental Immunology
- Population Pharmacokinetics and its Role in Anti-Tuberculosis Drug Development and Optimization of Treatment
- (2012) Eric Free Egelund et al. CURRENT PHARMACEUTICAL DESIGN
- Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
- (2012) Saverio De Lorenzo et al. EUROPEAN RESPIRATORY JOURNAL
- Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis [Case study]
- (2012) M. C. Payen et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- The chemotherapy of tuberculosis: past, present and future [State of the art]
- (2012) D. Mitchison et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Mass spectrometry imaging for drug distribution studies
- (2012) Brendan Prideaux et al. Journal of Proteomics
- Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
- (2012) P. L. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis
- (2012) S. Chakraborty et al. SCIENCE
- Fresh Approaches to Anti-Infective Therapies
- (2012) C. Nathan Science Translational Medicine
- Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death
- (2012) Roxane Simeone et al. PLoS Pathogens
- Phosphodiesterase-4 Inhibition Combined with Isoniazid Treatment of Rabbits with Pulmonary Tuberculosis Reduces Macrophage Activation and Lung Pathology
- (2011) Selvakumar Subbian et al. AMERICAN JOURNAL OF PATHOLOGY
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux
- (2011) Gail E. Louw et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- High-Sensitivity MALDI-MRM-MS Imaging of Moxifloxacin Distribution in Tuberculosis-Infected Rabbit Lungs and Granulomatous Lesions
- (2011) Brendan Prideaux et al. ANALYTICAL CHEMISTRY
- Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
- (2011) Maria C. Kjellsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
- (2011) Kristin N. Adams et al. CELL
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- Penetration of Anti-Infective Agents into PulmonaryEpithelial Lining Fluid
- (2011) Keith A. Rodvold et al. CLINICAL PHARMACOKINETICS
- Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin
- (2011) Sylvain Goutelle et al. JOURNAL OF THEORETICAL BIOLOGY
- Liposomes as drug delivery systems for the treatment of TB
- (2011) Marina Pinheiro et al. Nanomedicine
- Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy
- (2011) Caroline Colijn et al. PLoS One
- Location of Intra- and Extracellular M. tuberculosis Populations in Lungs of Mice and Guinea Pigs during Disease Progression and after Drug Treatment
- (2011) Donald R. Hoff et al. PLoS One
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
- (2011) W. Shi et al. SCIENCE
- Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases
- (2010) Clinton R. Nishida et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Radiosynthesis and Bioimaging of the Tuberculosis Chemotherapeutics Isoniazid, Rifampicin and Pyrazinamide in Baboons
- (2010) Li Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
- (2010) José A Caminero et al. LANCET INFECTIOUS DISEASES
- Nanobead-based interventions for the treatment and prevention of tuberculosis
- (2010) Gareth Griffiths et al. NATURE REVIEWS MICROBIOLOGY
- Multiple M. tuberculosis Phenotypes in Mouse and Guinea Pig Lung Tissue Revealed by a Dual-Staining Approach
- (2010) Gavin J. Ryan et al. PLoS One
- Computational framework for predictive biodegradation
- (2009) Stacey D. Finley et al. BIOTECHNOLOGY AND BIOENGINEERING
- The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection
- (2009) J. Muse Davis et al. CELL
- Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB
- (2009) Seok-Yong Eum et al. CHEST
- Foamy macrophages and the progression of the human tuberculosis granuloma
- (2009) David G Russell et al. NATURE IMMUNOLOGY
- The Granuloma in Tuberculosis — Friend or Foe?
- (2009) Eric J. Rubin NEW ENGLAND JOURNAL OF MEDICINE
- MDR-/XDR-TB management: what it was, current standards and what is ahead
- (2009) Ignacio Monedero et al. Expert Review of Respiratory Medicine
- Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes
- (2008) S. Van de Velde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
- (2007) James C. Sacchettini et al. NATURE REVIEWS MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now